Cargando…

Correction to: “Carbamylated Erythropoietin: A Prospective Drug Candidate for Neuroprotection”

Detalles Bibliográficos
Autores principales:	Chen, Jianmin, Yang, Zheng, Zhang, Xiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2016
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902041/ https://www.ncbi.nlm.nih.gov/pubmed/27330301 http://dx.doi.org/10.4137/BCI.S40221

Ejemplares similares

Carbamylated Erythropoietin: A Prospective Drug Candidate for Neuroprotection
por: Chen, Jianmin, et al.
Publicado: (2016)

Effect of Carbamylated Erythropoietin in a Chronic Model of TNBS-Induced Colitis
por: Silva, Inês, et al.
Publicado: (2023)

Molecular mechanism of the role of carbamyl erythropoietin in treating diabetic retinopathy rats
por: Xu, Xuegu, et al.
Publicado: (2018)

Comparison of Neurite Outgrowth Induced by Erythropoietin (EPO) and Carbamylated Erythropoietin (CEPO) in Hippocampal Neural Progenitor Cells
por: Oh, Dong Hoon, et al.
Publicado: (2012)

Spinal Stroke: Outcome Attenuation by Erythropoietin and Carbamylated Erythropoietin and Its Prediction by Sphingosine-1-Phosphate Serum Levels in Mice
por: Koepke, Leon-Gordian, et al.
Publicado: (2022)

Comparison of carbamylated versus recombinant erythropoietin during spinal cord ischemia/reperfusion injury
por: Simon, F, et al.
Publicado: (2010)

Effect of carbamylated erythropoietin on neuronal apoptosis in fetal rats during intrauterine hypoxic-ischemic encephalopathy
por: Diao, Min, et al.
Publicado: (2019)

Carbamylated erythropoietin attenuates cardiomyopathy via PI3K/Akt activation in rats with diabetic cardiomyopathy
por: HE, HONGYING, et al.
Publicado: (2013)

Carbamylated Erythropoietin Decreased Proliferation and Neurogenesis in the Subventricular Zone, but Not the Dentate Gyrus, After Irradiation to the Developing Rat Brain
por: Osato, Kazuhiro, et al.
Publicado: (2018)

Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies
por: Nakabo, Shuichiro, et al.
Publicado: (2017)

Comparison of homocitrulline and carbamylated albumin as biomarkers of carbamylation reactions in hemodialyzed patients
por: Lenglet, Aurelie, et al.
Publicado: (2023)

Carbamylated lipoproteins in diabetes
por: Denimal, Damien
Publicado: (2023)

Carbamylated erythropoietin regulates immune responses and promotes long-term kidney allograft survival through activation of PI3K/AKT signaling
por: Na, Ning, et al.
Publicado: (2020)

Erythropoietin: a multimodal neuroprotective agent
por: Byts, Nadiya, et al.
Publicado: (2009)

Protein Carbamylation and Cardiovascular Disease
por: Verbrugge, Frederik H., et al.
Publicado: (2015)

Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor
por: Hernández, Carolina Castillo, et al.
Publicado: (2017)

Correction to: Designing optimized drug candidates with Generative Adversarial Network
por: Abbasi, Maryam, et al.
Publicado: (2022)

Correction to: Leukemia inhibitory factor inhibits erythropoietin-induced myelin gene expression in oligodendrocytes
por: Gyetvai, Georgina, et al.
Publicado: (2020)

Neuroprotective Effects of Erythropoietin in Acute Ischemic Stroke
por: Asadi, Bahador, et al.
Publicado: (2013)

Endogenous Carbamylation of Renal Medullary Proteins
por: Claxton, J'Neka S., et al.
Publicado: (2013)

Citrullination and Carbamylation in the Pathophysiology of Rheumatoid Arthritis
por: Pruijn, Ger J. M.
Publicado: (2015)

Erythropoietin as a Neuroprotective Drug for Newborn Infants: Ten Years after the First Use
por: Perrone, Serafina, et al.
Publicado: (2022)

Erythropoietin; a Novel Neuroprotective Agent for Ocular Disorders
por: Falavarjani, Khalil Ghasemi, et al.
Publicado: (2011)

Neuroprotective mechanisms of erythropoietin in a rat stroke model
por: Juenemann, Martin, et al.
Publicado: (2020)

Author Correction: Neuroprotectants attenuate hypobaric hypoxia-induced brain injuries in cynomolgus monkeys
por: Zhang, Pei, et al.
Publicado: (2021)

Correction: Identification of Therapeutic Candidates for Chronic Lymphocytic Leukemia from a Library of Approved Drugs
por: Shen, Min, et al.
Publicado: (2013)

PON-1 carbamylation is enhanced in HDL of uremia patients
por: Chang, Chiz-Tzung, et al.
Publicado: (2018)

Correction: Erythropoietin-Derived Nonerythropoietic Peptide Ameliorates Experimental Autoimmune Neuritis by Inflammation Suppression and Tissue Protection
Publicado: (2014)

Neuroprotective effects of erythropoietin on rat retinas subjected to oligemia
por: de Carvalho, Litia Alves, et al.
Publicado: (2018)

The effect of carbamylation on the functionality of high-density lipoprotein
por: Holzer, Michael, et al.
Publicado: (2009)

Proteasome-dependent degradation of intracellular carbamylated proteins
por: Desmons, Aurore, et al.
Publicado: (2019)

Anti-carbamylated protein antibodies in systemic sclerosis
por: Liem, Sophie I. E., et al.
Publicado: (2023)

Association of carbamylated high-density lipoprotein with coronary artery disease in type 2 diabetes mellitus: carbamylated high-density lipoprotein of patients promotes monocyte adhesion
por: Chen, Zhongli, et al.
Publicado: (2020)

Correction to: The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion
por: Park, Sophie, et al.
Publicado: (2019)

The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage
por: Yoo, Seung-Jun, et al.
Publicado: (2017)

Neuroprotective potential of erythropoietin in neonates; design of a randomized trial
por: Juul, Sandra E., et al.
Publicado: (2015)

Author Correction: EPO does not promote interaction between the erythropoietin and beta-common receptors
por: Cheung Tung Shing, Karen S., et al.
Publicado: (2019)

Correction: Rapamycin Is Neuroprotective in a Rat Chronic Hypertensive Glaucoma Model
por: Su, Wenru, et al.
Publicado: (2019)

Correction: Granulocyte Colony-Stimulating Factor Activating HIF-1α Acts Synergistically with Erythropoietin to Promote Tissue Plasticity
por: Liu, Shih-Ping, et al.
Publicado: (2010)

Correction: Overexpression of MyrAkt1 in Endothelial Cells Leads to Erythropoietin- and BMP4-Independent Splenic Erythropoiesis in Mice
por: O’Donnell, Rebekah K., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jqftk2pqn9ugntf6qm3j5kk16s